These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

780 related items for PubMed ID: 26180207

  • 1. Network Disruption and Cerebrospinal Fluid Amyloid-Beta and Phospho-Tau Levels in Mild Cognitive Impairment.
    Canuet L, Pusil S, López ME, Bajo R, Pineda-Pardo JÁ, Cuesta P, Gálvez G, Gaztelu JM, Lourido D, García-Ribas G, Maestú F.
    J Neurosci; 2015 Jul 15; 35(28):10325-30. PubMed ID: 26180207
    [Abstract] [Full Text] [Related]

  • 2. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.
    Li X, Li TQ, Andreasen N, Wiberg MK, Westman E, Wahlund LO.
    J Intern Med; 2014 Apr 15; 275(4):418-27. PubMed ID: 24237038
    [Abstract] [Full Text] [Related]

  • 3. Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis.
    Kim WH, Racine AM, Adluru N, Hwang SJ, Blennow K, Zetterberg H, Carlsson CM, Asthana S, Koscik RL, Johnson SC, Bendlin BB, Singh V.
    Neuroimage Clin; 2019 Apr 15; 21():101586. PubMed ID: 30502079
    [Abstract] [Full Text] [Related]

  • 4. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH, Cogo-Moreira H, Rabin JS, Black SE, Swardfager W, Alzheimer's Disease Neuroimaging Initiative.
    J Neurosci; 2019 Sep 11; 39(37):7428-7437. PubMed ID: 31350262
    [Abstract] [Full Text] [Related]

  • 5. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C, Tucholka A, Monté-Rubio GC, Cacciaglia R, Operto G, Rami L, Gispert JD, Molinuevo JL, Alzheimer's Disease Neuroimaging Initiative.
    Neuroimage Clin; 2018 Sep 11; 19():190-201. PubMed ID: 30023169
    [Abstract] [Full Text] [Related]

  • 6. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H, Therriault J, Kang MS, Ng KP, Pascoal TA, Rosa-Neto P, Gauthier S, Alzheimer’s Disease Neuroimaging Initiative.
    Alzheimers Res Ther; 2018 Aug 16; 10(1):80. PubMed ID: 30115118
    [Abstract] [Full Text] [Related]

  • 7. Earliest amyloid and tau deposition modulate the influence of limbic networks during closed-loop hippocampal downregulation.
    Skouras S, Torner J, Andersson P, Koush Y, Falcon C, Minguillon C, Fauria K, Alpiste F, Blenow K, Zetterberg H, Gispert JD, Molinuevo JL, ALFA Study.
    Brain; 2020 Mar 01; 143(3):976-992. PubMed ID: 32091109
    [Abstract] [Full Text] [Related]

  • 8. A data-driven model of biomarker changes in sporadic Alzheimer's disease.
    Young AL, Oxtoby NP, Daga P, Cash DM, Fox NC, Ourselin S, Schott JM, Alexander DC, Alzheimer’s Disease Neuroimaging Initiative.
    Brain; 2014 Sep 01; 137(Pt 9):2564-77. PubMed ID: 25012224
    [Abstract] [Full Text] [Related]

  • 9. Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease.
    Marizzoni M, Ferrari C, Macis A, Jovicich J, Albani D, Babiloni C, Cavaliere L, Didic M, Forloni G, Galluzzi S, Hoffmann KT, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Pizzini F, Rossini PM, Salvatore M, Schönknecht P, Soricelli A, Del Percio C, Hensch T, Hegerl U, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB, PharmaCog Consortium.
    J Alzheimers Dis; 2019 Sep 01; 69(1):49-58. PubMed ID: 30958351
    [Abstract] [Full Text] [Related]

  • 10. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.
    Rosenberg A, Solomon A, Jelic V, Hagman G, Bogdanovic N, Kivipelto M.
    Alzheimers Res Ther; 2019 Dec 05; 11(1):99. PubMed ID: 31805990
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of functional compensation, delineated by eigenvector centrality mapping, across the pathophysiological continuum of Alzheimer's disease.
    Skouras S, Falcon C, Tucholka A, Rami L, Sanchez-Valle R, Lladó A, Gispert JD, Molinuevo JL.
    Neuroimage Clin; 2019 Dec 05; 22():101777. PubMed ID: 30913531
    [Abstract] [Full Text] [Related]

  • 12. Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment.
    Selnes P, Aarsland D, Bjørnerud A, Gjerstad L, Wallin A, Hessen E, Reinvang I, Grambaite R, Auning E, Kjærvik VK, Due-Tønnessen P, Stenset V, Fladby T.
    J Alzheimers Dis; 2013 Dec 05; 33(3):723-36. PubMed ID: 23186987
    [Abstract] [Full Text] [Related]

  • 13. Intrinsic functional connectivity, CSF biomarker profiles and their relation to cognitive function in mild cognitive impairment.
    Matura S, Köhler J, Reif A, Fusser F, Karakaya T, Scheibe M, Ehret F, Hartmann D, Kang JS, Mayer C, Prvulovic D, Pantel J.
    Acta Neuropsychiatr; 2020 Aug 05; 32(4):206-213. PubMed ID: 31801648
    [Abstract] [Full Text] [Related]

  • 14. Cholesterol metabolites and plant sterols in cerebrospinal fluid are associated with Alzheimer's cerebral pathology and clinical disease progression.
    Jahn T, Clark C, Kerksiek A, Lewczuk P, Lütjohann D, Popp J.
    J Steroid Biochem Mol Biol; 2021 Jan 05; 205():105785. PubMed ID: 33171206
    [Abstract] [Full Text] [Related]

  • 15. Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease.
    Drake JD, Chambers AB, Ott BR, Daiello LA, Alzheimer’s Disease Neuroimaging Initiative.
    J Alzheimers Dis; 2021 Jan 05; 80(4):1553-1565. PubMed ID: 33720880
    [Abstract] [Full Text] [Related]

  • 16. Association of Cerebrospinal Fluid S100B Protein with Core Biomarkers and Cognitive Deficits in Prodromal and Mild Alzheimer's Disease.
    Christl J, Verhülsdonk S, Pessanha F, Menge T, Seitz RJ, Kujovic M, Höft B, Supprian T, Lange-Asschenfeldt C.
    J Alzheimers Dis; 2019 Jan 05; 72(4):1119-1127. PubMed ID: 31683478
    [Abstract] [Full Text] [Related]

  • 17. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L, Peters O, Lewczuk P, Gruber O, Teipel SJ, Gertz HJ, Jahn H, Jessen F, Kurz A, Luckhaus C, Hüll M, Pantel J, Reischies FM, Schröder J, Wagner M, Rienhoff O, Wolf S, Bauer C, Schuchhardt J, Heuser I, Rüther E, Henn F, Maier W, Wiltfang J, Kornhuber J.
    Alzheimers Res Ther; 2017 Oct 10; 9(1):84. PubMed ID: 29017593
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.